<i id='DD358F7B7B'><strike id='DD358F7B7B'><tt id='DD358F7B7B'><pre id='DD358F7B7B'></pre></tt></strike></i>
EQRx is done, sold for its cash.
The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.
advertisement
The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad
read more
AdobeInMay,aNationalPublicRadiostoryasked,“Canachatbothelppeoplewitheatingdisordersaswellasanotherhu
read more
AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi
read moreActorKevinSpaceyarrivesatSouthwarkCrownCourtwhereheisaccusedofsexualoffensesagainstfourmenwhilehewor
